+919405117673

Respiratory Medicine

Trelegy Ellipta Inhaler

In stock

Description

Trelegy Ellipta Inhaler – Uses, Benefits & Therapeutic Advantage

Cordium Pharmaceuticals Pvt Ltd, a trusted pharmaceutical exporter from India, supplies Trelegy Ellipta Inhaler for international markets with reliable documentation, quality-focused sourcing, and fast delivery support.

Trelegy Ellipta Inhaler is a combination respiratory medicine containing Fluticasone Furoate + Umeclidinium + Vilanterol. It is used in the management of chronic respiratory conditions such as COPD (Chronic Obstructive Pulmonary Disease) under medical supervision.

Key Benefits & Effects

• Helps improve airflow and breathing comfort

• Supports long-term COPD symptom management

• Reduces airway inflammation

• Helps relax airway muscles for easier breathing

• Convenient once-daily inhalation format (as prescribed)

• Triple-action respiratory therapy approach

Therapeutic Category

Respiratory / Pulmonary Medicine – COPD Maintenance Therapy

Export Availability

Cordium Pharmaceuticals Pvt Ltd exports Trelegy Ellipta Inhaler from India to:

🇺🇸 USA – New York, California, Texas, Florida, New Jersey

Demand: Pulmonology clinics, hospitals, specialty pharmacies

🇬🇧 UK – London, Manchester, Birmingham, Glasgow

Demand: Respiratory care centres, healthcare distributors

🇦🇪 UAE – Dubai, Abu Dhabi, Sharjah

Demand: Medical distributors, pharmacies, hospitals

🇿🇦 South Africa – Johannesburg, Cape Town, Durban, Pretoria

Demand: Respiratory healthcare suppliers

🇰🇪 Kenya – Nairobi, Mombasa, Kisumu

Demand: Pharmacies, healthcare importers

🇻🇳 Vietnam – Ho Chi Minh City, Hanoi, Da Nang

Demand: Pharmaceutical wholesalers, hospitals

🇸🇬 Singapore – Singapore City

Demand: Specialty healthcare distributors

Why Choose Cordium Pharmaceuticals Pvt Ltd?

✓ Indian pharmaceutical exporter

✓ Global supply support

✓ Quality-assured pharmaceutical sourcing

✓ Export documentation assistance

✓ Fast international delivery coordination

✓ Hospital, distributor & pharmacy enquiries welcomed

Keywords